We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$141M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$127M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$109M
4
MRK icon
Merck
MRK
+$97.7M
5
ZBH icon
Zimmer Biomet
ZBH
+$80.8M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCK icon
26
Crown Holdings
CCK
$13.1B
$111M 0.71%
1,444,247
+506,501
+54% +$37.1M
MRK icon
27
Merck
MRK
$318B
$110M 0.7%
1,389,343
+1,247,771
+881% +$97.7M
LOW icon
28
Lowe's Companies
LOW
$125B
$110M 0.7%
660,593
-94,108
-12% -$14.5M
HOLX
29
DELISTED
Hologic
HOLX
$100M 0.64%
1,510,879
-1,132,035
-43% -$71.7M
PODD icon
30
Insulet
PODD
$9.79B
$96.3M 0.62%
407,038
-329,410
-45% -$69.4M
BAX icon
31
Baxter International
BAX
$14.2B
$92.8M 0.59%
1,154,558
+201,396
+21% +$16.9M
AVGO icon
32
Broadcom
AVGO
$2.04T
$88.3M 0.57%
2,424,710
+23,190
+1% +$777K
ASH icon
33
Ashland
ASH
$3.5B
$86.6M 0.55%
1,221,236
+169,882
+16% +$12.6M
GPN icon
34
Global Payments
GPN
$22.8B
$86.2M 0.55%
485,406
+170,525
+54% +$29.5M
MELI icon
35
Mercado Libre
MELI
$92.3B
$86M 0.55%
79,402
+35,230
+80% +$38.2M
AMED
36
DELISTED
Amedisys
AMED
$85.7M 0.55%
362,462
-85,327
-19% -$19.4M
COST icon
37
Costco
COST
$420B
$84.9M 0.54%
239,129
+195,978
+454% +$65.9M
SEE
38
DELISTED
Sealed Air
SEE
$84.6M 0.54%
2,179,583
-231,278
-10% -$8.81M
WFC icon
39
Wells Fargo
WFC
$264B
$83.1M 0.53%
3,534,588
-610,706
-15% -$15M
MS icon
40
Morgan Stanley
MS
$340B
$80M 0.51%
1,653,847
+1,522,758
+1,162% +$76.7M
AES icon
41
AES
AES
$10.5B
$79M 0.51%
4,363,501
+3,627,268
+493% +$60.6M
PNR icon
42
Pentair
PNR
$11B
$78.6M 0.5%
1,717,844
+210,843
+14% +$9.18M
CHNG
43
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$76.9M 0.49%
5,301,522
+1,794,459
+51% +$22.8M
BMRN icon
44
BioMarin Pharmaceuticals
BMRN
$12.4B
$75.5M 0.48%
992,855
+521,365
+111% +$52.7M
ARNA
45
DELISTED
Arena Pharmaceuticals Inc
ARNA
$74.6M 0.48%
997,396
-359,222
-26% -$24M
GS icon
46
Goldman Sachs
GS
$303B
$70.5M 0.45%
350,793
+285,989
+441% +$58.2M
INFO
47
DELISTED
IHS Markit Ltd. Common Shares
INFO
$69.9M 0.45%
889,835
+123,935
+16% +$9.87M
OTIS icon
48
Otis Worldwide
OTIS
$28.2B
$69.7M 0.45%
1,117,033
-101,148
-8% -$6.19M
SSNC icon
49
SS&C Technologies
SSNC
$18.6B
$69.6M 0.45%
1,150,178
-102,121
-8% -$6.11M
DD icon
50
DuPont de Nemours
DD
$19.2B
$67.7M 0.43%
972,819
+511,522
+111% +$35.8M
1
2
3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.